Somatoform disorders in the family doctor's practice
Somatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dnipro State Medical University
2013-10-01
|
Series: | Medičnì Perspektivi |
Subjects: | |
Online Access: | http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1846095632903700480 |
---|---|
author | Prykhodko V. Mikropulo I. Oleinik M. Kononenko E. Moreva D. Gogol O. Kashkovskiy D. Lisnyak O. Lisnyak A. |
author_facet | Prykhodko V. Mikropulo I. Oleinik M. Kononenko E. Moreva D. Gogol O. Kashkovskiy D. Lisnyak O. Lisnyak A. |
author_sort | Prykhodko V. |
collection | DOAJ |
description | Somatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include somatization disorder, undifferentiated somatoform disorder, hypocho¬n¬driacal disorder, somatoform dysfunction of the autonomic nervous system and stable somatoform pain disorder. The first part of the article reviewes features of the clinical manifestations of somatization disorder and undifferentiated somatoform disorder. Role of non-benzodiazepine tranquilizers (ADAPTOL) and metabolic drugs (VASONAT) in the treatment of patients with somatoform disorders is discussed. In review article data of neurologists and cardiologists on the effectiveness of anxiolytic drug ADAPTOL and metabolic drug VASONAT in different clinical groups of patients (coronary artery disease, chronic ischemia of the brain), which can significantly improve quality of life, increase exercise tolerance, improve cognitive function and correct mental and emotional disorders are presented. |
format | Article |
id | doaj-art-15ef9d1c19304b1db27e2af7f9a03d6e |
institution | Kabale University |
issn | 2307-0404 2307-0404 |
language | English |
publishDate | 2013-10-01 |
publisher | Dnipro State Medical University |
record_format | Article |
series | Medičnì Perspektivi |
spelling | doaj-art-15ef9d1c19304b1db27e2af7f9a03d6e2025-01-02T09:46:06ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042307-04042013-10-011831524Somatoform disorders in the family doctor's practicePrykhodko V.0Mikropulo I.1Oleinik M.2Kononenko E.3Moreva D.4Gogol O.5Kashkovskiy D.6Lisnyak O.7Lisnyak A. 8National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.National medical academy of postgraduate training named after Shupik P.L.Kyiv City Clinical Hospital for disabled war veteransKyiv City Clinical Hospital for disabled war veteransSomatoform disorders – psychogenic diseases are characterized by pathological physical symptoms that resemble somatic illness. Thus, any organic manifestations, which can be attributed to known diseases are not detected, but there are non-specific functional impairments. Somatoform disorders include somatization disorder, undifferentiated somatoform disorder, hypocho¬n¬driacal disorder, somatoform dysfunction of the autonomic nervous system and stable somatoform pain disorder. The first part of the article reviewes features of the clinical manifestations of somatization disorder and undifferentiated somatoform disorder. Role of non-benzodiazepine tranquilizers (ADAPTOL) and metabolic drugs (VASONAT) in the treatment of patients with somatoform disorders is discussed. In review article data of neurologists and cardiologists on the effectiveness of anxiolytic drug ADAPTOL and metabolic drug VASONAT in different clinical groups of patients (coronary artery disease, chronic ischemia of the brain), which can significantly improve quality of life, increase exercise tolerance, improve cognitive function and correct mental and emotional disorders are presented.http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdfsomatoformic disordersvegetative dysfunctionmethabolic therapyanxiolytics |
spellingShingle | Prykhodko V. Mikropulo I. Oleinik M. Kononenko E. Moreva D. Gogol O. Kashkovskiy D. Lisnyak O. Lisnyak A. Somatoform disorders in the family doctor's practice Medičnì Perspektivi somatoformic disorders vegetative dysfunction methabolic therapy anxiolytics |
title | Somatoform disorders in the family doctor's practice |
title_full | Somatoform disorders in the family doctor's practice |
title_fullStr | Somatoform disorders in the family doctor's practice |
title_full_unstemmed | Somatoform disorders in the family doctor's practice |
title_short | Somatoform disorders in the family doctor's practice |
title_sort | somatoform disorders in the family doctor s practice |
topic | somatoformic disorders vegetative dysfunction methabolic therapy anxiolytics |
url | http://medpers.dsma.dp.ua/issues/2013/N3/15-24.pdf |
work_keys_str_mv | AT prykhodkov somatoformdisordersinthefamilydoctorspractice AT mikropuloi somatoformdisordersinthefamilydoctorspractice AT oleinikm somatoformdisordersinthefamilydoctorspractice AT kononenkoe somatoformdisordersinthefamilydoctorspractice AT morevad somatoformdisordersinthefamilydoctorspractice AT gogolo somatoformdisordersinthefamilydoctorspractice AT kashkovskiyd somatoformdisordersinthefamilydoctorspractice AT lisnyako somatoformdisordersinthefamilydoctorspractice AT lisnyaka somatoformdisordersinthefamilydoctorspractice |